Global Hemoglobin A1C Testing Market, Forecast to 2028

Healthcare Global Hemoglobin A1C Testing Market, Forecast to 2028

Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing

INDUSTRY
Healthcare

RELEASE DATE
20-Oct-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K960-01-00-00-00
SKU
HC_2023_255
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC_2023_255

Global Hemoglobin A1C Testing Market, Forecast to 2028
Published on: 20-Oct-2023 | SKU: HC_2023_255

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the HbA1c Testing Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of the Study

Segmentation by Setting

Segmentation by End Users

Segmentation by Technology

Key Competitors

Global Diabetes Highlights, 2021

Number of People with Diabetes, 2021–2045

Top 10 Countries or Territories for Number of Adults

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast by Region

Revenue Forecast Analysis by Region

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast By Setting

Revenue Forecast Analysis by Setting

Revenue Forecast Analysis by Setting (continued)

Revenue Forecast by End Users

Revenue Forecast Analysis by End Users

Revenue Forecast by Technology

Revenue Forecast Analysis by Technology

Revenue Forecast Analysis by Technology (continued)

Pricing Trends and Analysis

Pricing Trends and Analysis (continued)

Key Pricing Strategies Adopted by Players

Future Aspect of Pricing

Global HbA1c Testing Market—Notable Activities

Global HbA1c Testing Market—Notable Activities (continued)

Global HbA1c Testing Reimbursement Pathways

Competitive Environment

Companies to Watch—Abbott Laboratories

Companies to Watch—Roche Diagnostics

Companies to Watch—Siemens Healthineers

Companies to Watch—Beckman Coulter

Companies to Watch—Tosoh Corporation

Companies to Watch—Bio-Rad Laboratories

Companies to Watch—EKF Diagnostics

Companies to Watch—Erba Diagnostics, Inc.

Companies to Watch—Diazyme Laboratories

Companies to Watch—PTS Diagnostics

Companies to Watch—Trinity Biotech

Competitive Mapping by HbA1c Offering Parameters

Competitive Mapping by HbA1c Offering Parameters (continued)

Growth Opportunity Summary

Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics

Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics (continued)

Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing

Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing (continued)

Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets

Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets (continued)

Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management

Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

04 Aug 2026   |   Global   |   Market Research

Global Capnography Devices Market, Forecast to 2031

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...

31 Jul 2026   |   Global   |   Market Research

Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...

30 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.

The issue features advanced medical devices such as non-invasive bimoda...

30 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets. Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.
More Information
Deliverable Type Market Research
Author Chandni Hussain
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Global Diagnostic Testing Trends
Keyword 2 Hemoglobin A1C Test Forecast
Keyword 3 A1C Testing Market Analysis
Podcast No
WIP Number K960-01-00-00-00